SMARCB1 and pineal parenchymal cell neoplasm: For other pineal tumors, including pineal parenchymal tumor of intermediate differentiation, papillary tumor of the pineal region, and desmoplastic myxoid tumor, SMARCB1-mutant, clinical behavior, and histological grading criteria are yet to be defined, and the role of adjuvant postoperative therapy remains unclear.